(19)
(11) EP 3 227 680 A1

(12)

(43) Date of publication:
11.10.2017 Bulletin 2017/41

(21) Application number: 15865346.9

(22) Date of filing: 04.12.2015
(51) International Patent Classification (IPC): 
G01N 33/53(2006.01)
G01N 33/543(2006.01)
G01N 21/64(2006.01)
G01N 30/72(2006.01)
G01N 33/533(2006.01)
G01N 33/68(2006.01)
G01N 27/62(2006.01)
A61K 31/55(2006.01)
(86) International application number:
PCT/US2015/063952
(87) International publication number:
WO 2016/090228 (09.06.2016 Gazette 2016/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 05.12.2014 US 201462088118 P
23.01.2015 US 201562106863 P

(71) Applicants:
  • Myriad Genetics, Inc.
    Salt Lake City, UT 84108 (US)
  • Kaldate, Rajesh
    Salt Lake City, UT 84108 (US)

(72) Inventor:
  • KALDATE, Rajesh
    Salt Lake City, UT 84108 (US)

(74) Representative: Gibson, Mark 
Sagittarius IP Three Globeside Fieldhouse Lane
Marlow, Buckinghamshire SL7 1HZ
Marlow, Buckinghamshire SL7 1HZ (GB)

   


(54) BIOMARKERS FOR DISTINGUISHING MOOD DISORDERS